Solarea Bio

Headed to Future Food-Tech? Join us for an insightful session! On Friday, March 14, our CEO and Co-Founder Gerardo V. Toledo will present a case study titled "Mapping the Microbiome to Unlock Health Benefits Across Life Stages" with Biohm Technologies CEO Sam Schatz and Nimble Science CEO Sabina Bruehlmann. This session will delve into: ?? Identifying gaps in gut microbiome mapping and its translation to human health solutions. ?? Research needed to understand the microbiome's impact on need states such as cognition and immunity. ?? Leveraging innovations like biosensors and AI for data-driven insights. ?? Latest developments in prebiotics, probiotics, and postbiotics for specific health solutions. Don't miss this opportunity to gain valuable insights into the future of microbiome research and its applications in health. #Microbiome #HealthInnovation #FutureFoodTech #SolareaBio

We are thrilled to announce our participation in the Future Food-Tech summit in San Francisco on March 13-14, 2025. The event brings together global leaders who are committed to a healthy and sustainable future through food. Two highlights: ?? We are finalists in the Puratos Innovation Challenge and will present with the other finalists on March 13. The winner will be named later that day at the summit. ?? CEO Gerardo V. Toledo will present with Biohm Technologies CEO Sam Schatz and Nimble Science CEO Sabina Bruehlmann on, “Mapping the Microbiome to Unlock Health Benefits Across Life Stages” on Friday, March 14 at 11:55 a.m. Learn more in our press release: https://lnkd.in/exxByw6S We look forward to engaging with fellow innovators and exploring the latest advancements in food technology, including our first product, Bondia? (SBD111), a synbiotic medical food to aid in the dietary management of osteopenia and bone loss associated with menopause, weight, and age. #FutureFoodTech #JournaHealth #SolareaBio #FoodInnovation

Thanks to Femtech Insider for their coverage of Journa Health’s launch of Solarea Bio-developed Bondia?, a medical food to aid in the dietary management of bone loss associated with osteopenia, menopause, weight, and age. ? "Solutions for the age-related inflammatory condition osteopenia are a significant unmet need, as consumers lack safe and effective products to manage postmenopausal bone loss," said CEO Gerardo V. Toledo. ? Read the story to see how our AI-driven platform enables development of Bondia? and other medical foods: https://lnkd.in/ekngf5er #MedicalFood #BoneLoss #Osteopenia #Menopause

Don't miss Journa Health in booth 1211 at the Integrative Healthcare Symposium 2025 in NYC this week. Meet our team to explore how microbiome-based innovations are reshaping integrative #healthcare. ?? We're developing clinically validated medical foods like Bondia?, a #synbiotic medical food that aids in the dietary management of bone loss associated with #osteopenia, #menopause, weight, and age. #IHS2025

A growing body of research reinforces the gut’s role in systemic #health - from immune function to inflammatory balance and bone health. Journa Health is leading the way in microbiome-based #MedicalFoods, bringing clinically validated solutions like Bondia? to the forefront of integrative patient care. ?? Bondia? (SBD111) is a first-of-its-kind #synbiotic designed to aid in the dietary management of bone loss by enhancing gut barrier function and modulating osteoclast activity to reduce systemic inflammation. Next week, we’ll be at Integrative Healthcare Symposium 2025 in NYC to share the latest advancements in microbiome-targeted solutions and detail the #gut-bone axis. ?? If you’re attending IHS 2025, stop by booth # 1211 to explore how Bondia? can enhance patient outcomes. #IHS2025 #BoneHealth

We’re excited to share that Journa Health will exhibit at the Integrative Healthcare Symposium 2025 in New York City from February 20-22! ?? As healthcare continues to shift toward personalized, integrative solutions, we remain committed to pioneering #microbiome-based innovations that support whole-body health, like Bondia?, a new #synbiotic medical food that aids in the dietary management of bone loss associated with osteopenia, menopause, weight, and age. ?? Visit us at Booth 1211 to explore the clinical applications of Bondia? and learn how Journa is redefining the role of the gut microbiome in patient care. #IHS2025

Recent research has highlighted the gut’s contributions to overall health as well as an opportunity for healthcare providers to prioritize the gut #microbiome for improving patient outcomes. Recently, our Co-Founder and COO Eric Schott, PhD, joined Dr. Jeff Bland, PhD, for a Personalized Lifestyle Medicine Institute webinar, Enhancing Bone Health: Exploring the Role of Synbiotic Therapy, with Journa advisor Dr. Susan Bukata, MD, Chair, Department of Orthopedic Surgery, UC San Diego, to explore the gut-bone axis. ? If you didn’t get a chance to attend, check out Eric’s key takeaways from the in-depth conversations. Among the topics they reviewed were: managing #BoneHealth in clinical settings; how enhancing the #gut barrier function can help to reduce systemic inflammation; and how Bondia?, a new #synbiotic medical food, can target #osteoclast activity to improve outcomes for patients at risk of bone loss. ?? Click here to read his article:?https://lnkd.in/eFqGnN4V

We are thrilled to share that Solarea Bio has been selected as a finalist for the Puratos Innovation Challenge at the upcoming Future Food-Tech Summit in San Francisco. On March 13, 2025, our CEO and Co-founder Gerardo V. Toledo will take the stage to showcase how Solarea Bio is unlocking the power of the edible plant microbiota to provide natural solutions for patients suffering from inflammatory processes. The Puratos Innovation Challenge features innovative solutions that can modulate the gut microbiome to improve physical health or mental wellbeing. At Solarea Bio, we are dedicated to developing natural, microbe-based solutions to address underserved inflammatory conditions by isolating beneficial organisms from plants to formulate Synbiotic Medical Foods. ?? We are honored to be among three finalists presenting our solutions to Puratos and the Future Food-Tech audience. #FutureFoodTech #PuratosInnovationChallenge #GutHealth #Microbiome #SolareaBio

There is still time to sign up for tomorrow’s Personalized Lifestyle Medicine Institute free webinar on, “Enhancing Bone Health: Exploring the Role of Synbiotic Therapy,” sponsored by Journa. ??? Solarea Bio’s Co-Founder and COO Eric Schott, PhD, and Solarea Bio advisor and Chair of Orthopaedic Surgery at UCSD Susan Bukata, MD, will join Functional Medicine Founder and Pioneer Jeffrey Bland, PhD, for the conversation. ??? ?? The experts will review the connections of gut health, systemic inflammation, and bone metabolism and share clinical trial findings on a novel medical food, Bondia? (SBD111), to improve bone health. ?? ?? Sign up for your spot: https://lnkd.in/g2UQA_N2 #BoneHealth #GutHealth #Bondia #BoneLoss #SynbioticTherapy?

?? Discover the Gut-Bone Connection in an Upcoming Personalized Lifestyle Medicine Institute Webinar, sponsored by Journa ?? Solarea Bio invites healthcare professionals to explore the latest research on synbiotic therapy and its role in bone health. Discover clinical trial results on Bondia? (SBD111), a novel synbiotic medical food, to improve bone health for postmenopausal women. Event Details: ?? Topic: Enhancing Bone Health: Exploring the Role of Synbiotic Therapy? ?? Date: January 14, 2025? ?? Time: 5:00 PM PST Speakers: Jeffrey Bland, PhD, Functional Medicine Founder and Pioneer? Susan Bukata MD, Chair of Orthopaedic Surgery at the University of California San Diego? Eric Schott, PhD, Co-Founder and COO of Solarea Bio It’s free to register: https://lnkd.in/g2UQA_N2 #BoneHealth #GutHealth #Bondia #BoneLoss #SynbioticTherapy?